Zofaril 7,5 Mg & 30 Mg Tablet
PDF Leaflet Revision Date: 24 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension and acute myocardial infarction.
Dosage (summary)
Start with 15 mg once daily, titrate to 30 mg; max 60 mg/day.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Concomitant use with sacubitril/valsartan
- Potassium-sparing diuretics
- Lithium
Contraindications
- Hypersensitivity to zofenopril
- History of angioedema
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy
Common side effects
- Dizziness
- Cough
- Nausea
- Fatigue
Counselling Points
- Monitor blood pressure regularly.
- Report any signs of angioedema.
- Avoid potassium supplements.
Serious warnings
- Risk of hypotension
- Angioedema
- Neutropenia
Important Disclaimer
The Zofaril 7,5 Mg & 30 Mg Tablet professional information leaflet below is the property of Lebasi Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
